Accellent new name for post-MedSource UTI:
This article was originally published in Clinica
UTI, a contract manufacturing, design and engineering company serving the medical device sector, has been renamed Accellent. The change comes after the firm acquired Minneapolis, Minnesota-based MedSource for $230m in June. The new group will be headquartered in Boston, Massachusetts, and will retain a key manufacturing centre at Collegeville, Pennsylvania. The company has three divisions: orthopaedics and endoscopy (both based in the Boston area); and cardiology, in Minneapolis.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.